None of our directors or executive officers received any equity awards, including, options, restricted shares or other equity incentives in the fiscal year ended March 31, 2024.
Share Incentive Plan
2024 Global Equity Incentive Plan
In November 2024, we adopted the 2024 Global Equity Incentive Plan (the “2024 Plan”), which provides for the grant of share options, share appreciation rights, restricted share units, restricted shares or other share-based awards, which we refer to collectively as “equity awards”. We believe that the 2024 Plan will provide the eligible participants of the 2024 Plan an opportunity to benefit from the success of the Company and our affiliates through the granting of equity awards.
The initial maximum number of Shares which may be granted and issuable pursuant to the 2024 Plan is 1,707,500 Ordinary Shares, subject to the proportionate and equitable adjustments made by the board of directors of the Company (the “Board”) resulting from a share split, reverse stock split, combination, consolidation, sub-division, reclassification or similar events, the determination made by the Board in the event of a spin-off transaction or corporate transactions of the Company such as dissolution, liquidation, merger, consolidation or sale of all or substantially all of the assets of the Company, and the Board may, at its sole and absolute discretion, to make such adjustment or determination.
The following paragraphs describe the principal terms of the 2024 Plan.
Eligibility. The Board may grant one or more awards to an employee, director, consultant or sub-contractor of the Company or our affiliates who is selected by the Board to participate in the 2024 Plan.
Type of Awards. The 2024 Plan permits the awards of share options, restricted shares, restricted share units, share appreciation rights or other share-based awards, as determined by the board of directors.
Administration. The 2024 Planis administered by the Board or persons to whom the Board may delegate its duties and powers in whole or in part as it determines. The Board is authorized to construe and interpret the 2024 Plan, to prescribe, amend, and rescind any rules and regulations relating to the 2024 Plan, and to make any other determinations necessary, advisable or desirable for the administration of the 2024 Plan, as well as determine the form, timing and terms of each award consistent with the provisions of the 2024 Plan.
Award Agreements. Generally, equity awards granted under the 2024 Plan are evidenced by an award agreement providing for the number of Ordinary Shares subject to the award, and the terms and conditions of the award, which must be consistent with the 2024 Plan.
Vesting Schedule. The Board determines the vesting schedule of each equity award granted under the 2024 Plan, which vesting schedule will be subject to a certain number of months or years of services with the Company or our affiliates; and/or the performance criteria based on one or more performance factors as determined by the Board and set forth in the award agreement for such equity award.
Restriction on Transfer and Sale. The Board may, at its discretion, determine that the Shares issued or transferred to a participant pursuant to an option or restricted share units shall be restricted as to transferability and sale.
Term. Unless terminated earlier, the 2024 Plan will continue in effect for a term of ten years from the date of its adoption on November 18, 2024.
Termination or Amendment of Plan. The Board may amend, alter, or discontinue the 2024 Plan, subject to certain exceptions.
Restricted Share Units Grants
As of the date of this prospectus, we have granted a total of 814,005 Restricted Share Units (the “RSUs”) to our directors, employees or consultant, and there are a total of 88,758 Ordinary Shares underlying grants of outstanding RSUs that were held by the directors (including a director appointee) and executive officers the Company, which include the following:
• | CHU Chun On Franco (Director and Chief Executive Officer), who will own less than 1% of the outstanding Ordinary Shares on an as-converted basis, has outstanding RSUs granted on November 18, 2024, with a purchase price of US$4.50 per share and vesting dates that range from May 18, 2025 to November 18, 2026; |